drugset / Trial / NCT06431477

Efficacy and Safety of Telmisartan Compared With Losartan

NCT06431477

Phase 4 Unknown 98 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

A study to evaluate the efficacy and safety of telmisartan compared with losartan in patients with diabetic nephropathy and hypertension

Timeline

Start
2023-04-19
Primary completion
2025-10-31
Completion
2025-10-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Losartan Other / unclassified Oral
Subject Telmisartan Other / unclassified Oral